diabetes

Eli Lilly cuts ties with Transition, ends diabetes drug collaboration
BioPharma Dive
Tue, 04/19/16 - 10:24 am
Eli Lilly
Transition Therapeutics
diabetes
TT401
Diabetes Drug Shakeup: What You Need to Know About New FDA Warnings
Motley Fool
Tue, 04/19/16 - 09:50 am
FDA
diabetes
AstraZeneca
Takeda
Nesina
Onglyza
Eli Lilly
JNJ
Trajenta
Jardiance
Invokana
Eli Lilly And Boehringer Reveals Study On Jardiance For Treatment Heart Failure
Yahoo/Benzinga
Tue, 04/19/16 - 09:47 am
Eli Lilly
Boehringer Ingelheim
Jardiance
diabetes
chronic heart failure
Victoza to Fuel Growth for Novo Nordisk
Yahoo/Market Realist
Sat, 04/16/16 - 04:08 pm
Novo Nordisk
Victoza
diabetes
Diabetes drugs fuel cancer spread in mouse study
Stat
Wed, 04/13/16 - 10:26 pm
diabetes
cancer
Merck
Januvia
AstraZeneca
Onglyza
Medtronic touts insulin pump study
Mass Device
Wed, 04/13/16 - 10:21 am
Medtronic
insulin pumps
MiniMed Paradigm Veo
diabetes
devices
How Is Novo Nordisk Doing in the Diabetes Space?
Yahoo/Market Realist
Tue, 04/12/16 - 08:32 am
Novo Nordisk
diabetes
MannKind's Road To Riches - Sales, Sales And More Sales
Seeking Alpha
Tue, 04/12/16 - 07:47 am
MannKind
Afrezza
Sanofi
inhaled insulin
diabetes
Back in control of Afrezza, MannKind refocuses on endocrinologists to give launch a jolt
Fierce Pharma Marketing
Mon, 04/11/16 - 11:19 pm
MannKind
Afrezza
diabetes
Sanofi
inhaled insulin
MannKind to Discuss U.S. Commercialization Update for Afrezza
Yahoo
Mon, 04/11/16 - 09:56 am
MannKind
Afrezza
inhaled insulin
diabetes
Novo makes inroads in Japan with long-acting insulin Tresiba
Fierce Pharma
Fri, 04/8/16 - 09:54 pm
Japan
Novo Nordisk
diabetes
insulin
Tresiba
Diabetes rose fourfold over last 25 years, WHO says
Stat
Thu, 04/7/16 - 10:02 am
diabetes
WHO
FDA warns on heart failure risk associated with Onglyza, Nesina
BioPharma Dive
Wed, 04/6/16 - 10:13 pm
FDA
heart failure
Onglyza
Nesina
AstraZeneca
Takeda
diabetes
MannKind reworks commercial strategy for Afrezza
Medical Marketing and Media
Wed, 04/6/16 - 10:11 pm
MannKind
Afrezza
diabetes
Insulin prices have skyrocketed, putting drug makers on the defensive
Stat
Wed, 04/6/16 - 09:56 am
insulin
diabetes
drug pricing
Eli Lilly
Novo Nordisk
Medicare
MannKind Regains Afrezza® Marketing Rights
Yahoo
Tue, 04/5/16 - 08:46 pm
MannKind
Afrezza
Sanofi
inhaled insulin
diabetes
Novo Nordisk Follows Eli Lilly as Worthy Rival to Merck in Diabetes
Bidness, ETC
Tue, 03/8/16 - 10:14 am
Novo Nordisk
Eli Lilly
Merck
diabetes
Victoza
Express Scripts unimpressed by insulin data on Novo's Tresiba
BioPharma Dive
Thu, 03/3/16 - 10:41 am
Express Scripts
insulin
Novo Nordisk
diabetes
Tresiba
Lantus
Sanofi Joins Hands with JDRF for Breakthrough Diabetes Research
Bidness, ETC
Sun, 02/28/16 - 11:08 am
Sanofi
diabetes
JDRF
R&D
type 1 diabetes
Novo Nordisk notches another phase 3 success for GLP-1 drug
BioPharma Dive
Fri, 02/26/16 - 10:18 am
Novo Nordisk
diabetes
GLP-1 agonist
semaglutide

Pages